{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:49:53Z","timestamp":1788587393720,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijantimicag.2024.107346","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T16:33:44Z","timestamp":1727368424000},"page":"107346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Population pharmacokinetic analysis and dosing optimization of colistin sulphate in lung transplant recipients with pneumonia: A prospective study"],"prefix":"10.1016","volume":"64","author":[{"given":"Xiaojun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuben","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107346_bib0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0002","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0004","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1586\/eri.10.88","article-title":"Multidrug-resistant Gram-negative infections: the use of colistin","volume":"8","author":"Michalopoulos","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0005","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0006","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/679109","article-title":"Antibacterial mechanisms of polymyxin and bacterial resistance","volume":"2015","author":"Yu","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0008","article-title":"Polymyxins bind to the cell surface of unculturable Acinetobacter baumannii and cause unique dependent resistance","volume":"7","author":"Zhu","year":"2020","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0009","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","article-title":"Rescuing the last-line polymyxins: achievements and challenges","volume":"73","author":"Nang","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0010","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.00035-06","article-title":"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0011","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0012","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/ph14090903","article-title":"Population pharmacokinetics of colistin methanesulfonate sodium and colistin in critically ill patients: a systematic review","volume":"14","author":"Zabidi","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0013","article-title":"Population pharmacokinetics of colistin sulfate in critically ill patients: exposure and clinical efficacy","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0014","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1586\/14787210.2015.1093933","article-title":"Polymyxin B versus colistin: an update","volume":"13","author":"Cai","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkh167","article-title":"Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate","volume":"53","author":"Li","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0016","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.47.5.1766-1770.2003","article-title":"Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration","volume":"47","author":"Li","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107031","article-title":"Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: a real-world, retrospective cohort study","volume":"63","author":"Zhang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0018","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12879-023-08339-0","article-title":"Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0019","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/vetsci9110650","article-title":"Colistin use in European livestock: veterinary field data on trends and perspectives for further reduction","volume":"9","author":"Jansen","year":"2022","journal-title":"Vet Sci"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0020","first-page":"22","article-title":"Antimicrobial-resistant bacteria arising from the use of colistin sulfate in the livestock","volume":"9","year":"2021"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0021","first-page":"292","article-title":"Chinese Thoracic Society; Chinese Society of Critical Care Medicine","volume":"44","year":"2021","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0022","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciw839","article-title":"Dosing guidance for intravenous colistin in critically-ill patients","volume":"64","author":"Nation","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0023","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0030-1249119","article-title":"Complex bacterial infections pre- and posttransplant","volume":"31","author":"Lease","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0024","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.transproceed.2007.06.061","article-title":"Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation","volume":"39","author":"Linares","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/08971900221074967","article-title":"Colistin (polymyxin E) use in abdominal solid organ transplant recipients","volume":"36","author":"Krishnakumar","year":"2023","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0026","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/j.1600-6143.2007.01964.x","article-title":"Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain","volume":"7","author":"Moreno","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tid.12471","article-title":"Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation","volume":"18","author":"Tebano","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0028","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOT.0000000000000782","article-title":"Multidrug-resistant bacteria in lung transplantation","volume":"25","author":"Dominguez","year":"2020","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154315","article-title":"Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"77","author":"Zhang","year":"2023","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/1120009X.2023.2219590","article-title":"Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients","volume":"36","author":"Dvorackova","year":"2024","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0031","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/AAC.00030-09","article-title":"Renal disposition of colistin in the isolated perfused rat kidney","volume":"53","author":"Ma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0032","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/bcp.15061","article-title":"Trough polymyxin B plasma concentration is an independent risk factor for its nephrotoxicity","volume":"88","author":"Han","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0033","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.01367-09","article-title":"Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry","volume":"54","author":"Gobin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0034","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/AAC.01114-09","article-title":"Elucidation of the pharmacokinetic\/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models","volume":"54","author":"Dudhani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0035","first-page":"3291","article-title":"New pharmacokinetic\/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection","volume":"70","author":"Cheah","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00483-18","article-title":"Personalizing polymyxin B dosing using an adaptive feedback control algorithm","volume":"62","author":"Lakota","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00276-21","article-title":"Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)","volume":"60","author":"Giske","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0038","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkx409","article-title":"Pharmacokinetics\/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models","volume":"73","author":"Landersdorfer","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0039","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cpt.981","article-title":"Population pharmacokinetics of polymyxin B","volume":"104","author":"Manchandani","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01493-17","article-title":"Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples","volume":"62","author":"Kubin","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01900-20","article-title":"Comparing the population pharmacokinetics of and acute kidney injury due to polymyxin B in Chinese patients with or without renal insufficiency","volume":"65","author":"Wang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0042","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cmi.2023.05.018","article-title":"A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients","volume":"29","author":"Hanafin","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0043","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/AAC.00030-09","article-title":"Renal disposition of colistin in the isolated perfused rat kidney","volume":"53","author":"Ma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260312","article-title":"Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: an updated systematic review and meta-analysis","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.21037\/atm-22-4959","article-title":"Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant Gram-negative bacterial infections: a retrospective cohort study","volume":"10","author":"Jin","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.967412","article-title":"Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1019411","article-title":"Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: a prospective study","volume":"13","author":"Cai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0048","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s40262-017-0561-1","article-title":"Clinical pharmacokinetics and pharmacodynamics of colistin","volume":"56","author":"Gr\u00e9goire","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0049","doi-asserted-by":"crossref","first-page":"785893","DOI":"10.3389\/fphar.2021.785893","article-title":"Pharmacokinetic\/pharmacodynamic based breakpoints of polymyxin B for bloodstream infections caused by multidrug-resistant Gram-negative pathogens","volume":"12","author":"Bian","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107346_bib0050","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1093\/cid\/ciaa121","article-title":"Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing position statements on polymyxin B and colistin clinical breakpoints","volume":"71","author":"Satlin","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T19:31:19Z","timestamp":1732822279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924002620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0924857924002620"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107346","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetic analysis and dosing optimization of colistin sulphate in lung transplant recipients with pneumonia: A prospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107346"}}